| For: | Subramanian A, Jahabardeen A, Thamaraikani T, Vellapandian C. More on the interplay between gut microbiota, autophagy, and inflammatory bowel disease is needed. World J Gastroenterol 2024; 30(27): 3356-3360 [PMID: 39086745 DOI: 10.3748/wjg.v30.i27.3356] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v30/i27/3356.htm |
| Number | Citing Articles |
| 1 |
Lijuan Bao, Lei Jin, Yang Yang, Yihong Zhao, Keyi Wu, Ruping Shan, Yi Liu, Yu Han, Shan Shang, Naisheng Zhang, Xiaoyu Hu, Yunhe Fu, Caijun Zhao, Hongyang Jiang, Wenchao Bian. Hexadecanamide alleviates experimental colitis in mice and modifies the gut microbiome. BMC Biology 2026; 24(1) doi: 10.1186/s12915-026-02530-w
|
| 2 |
Anis Hasnaoui, Racem Trigui, Mario Giuffrida. Gut microbiota and mesenteric adipose tissue interactions in shaping phenotypes and treatment strategies for Crohn’s disease. World Journal of Gastroenterology 2024; 30(46): 4969-4976 doi: 10.3748/wjg.v30.i46.4969
|
| 3 |
Siqing Chen, Zhang Qin, Xiaoyuan Lin, Sainan Zhou, Yin Xu, Ying Zhu. Macrophages: emerging targets for ulcerative colitis. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1623491
|
| 4 |
Sixuan Chen, Jing Guan, Xia Pang, Xi Chen, Min Li, Huan Wang, Fei Mao. Mitophagy in inflammatory bowel disease: regulatory mechanisms and therapeutic potential. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1804813
|
| 5 |
Lu Han, Yang Xie, Chunyan Zeng, Youxiang Chen. Targeting the RNF31–TFEB–NLRP3 Axis With a Curcumin Analog to Restore Autophagy and Alleviate Intestinal Inflammation. Food Science & Nutrition 2026; 14(5) doi: 10.1002/fsn3.71916
|
| 6 |
Mo-Wei Kong, Yang Yu, Peng Wang, Ying Wan, Yu Gao, Chun-Xiang Zhang. Advances in the research of intestinal fungi in Crohn's disease. World Journal of Gastroenterology 2024; 30(39): 4318-4323 doi: 10.3748/wjg.v30.i39.4318
|
| 7 |
Špela Konjar, Evgen Benedik, Marko Šestan, Marc Veldhoen, Anže Županič. Systems biology to unravel Western diet-associated triggers in inflammatory bowel disease. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1621334
|
| 8 |
Hao Xu, Ze-Hui Wang, Sheng-Lan Zhong, Tian Chen, Su-Zhi Liu, Song-Lin Zhang, Xiao-Xuan Xie, Te Liu, Wei Yang. Rhoifolin Attenuates DSS-Induced Colitis in Mice by Modulating Gut Microbiota and Restoring Th17/Treg Balance. Journal of Inflammation Research 2025; doi: 10.2147/JIR.S515002
|
| 9 |
Arunkumar Subramanian, Afrarahamed J, Tamilanban T, Vinoth Kumarasamy, M Yasmin Begum, Mahendran Sekar, Vetriselvan Subramaniyan, Ling Shing Wong, Adel Al Fatease. Exploring the Connections: Autophagy, Gut Microbiota, and Inflammatory Bowel Disease Pathogenesis. Journal of Inflammation Research 2024; doi: 10.2147/JIR.S483958
|
| 10 |
Chuxiao Chen, Zongwei Yang, Jun Guo, Yinzhi Liu, Xiaoting Yang, Weiping Deng, Hanyang Yu, Shumei Yang. Causal genetic link between gut microbiome, metabolites, and autism spectrum disorder in a European cohort. Medicine 2025; 104(52) doi: 10.1097/MD.0000000000046526
|
| 11 |
Caiyi Yuan, Qiang Wang, Yuying Chen, Xin Ding, Qiang Zhang, Jiakai Yao, Bei Zhang, Yang Dai, Hongxia Bai. Protective effects of Nippostrongylus brasiliensis-derived uridine via the apical sodium-dependent bile acid transporter in a mouse model of TNBS-induced inflammatory bowel disease. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1600838
|
| 12 |
Zishao Tao, Li Li, Ying Zhang, Yufang Tang, Simeng Zhang, Heying Yang, Guorong Jiang, Rui Zhang, Zhiwei Wu, Miao He. The role of the tuft cell–interleukin-25 axis in the pathogenesis of inflammatory bowel disease. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1629060
|
| 13 |
Xiaoming Liu, Yujie Chen, Yong Liu, Yang Hu, Keke Wang, Lixin Huang, Xiquan Ke, Lei Peng, Zhiguo Guo. Protective effects and mechanisms of extracts of Gleditsia sinensis Lam. Thorn on DSS-induced colitis in mice. Journal of Ethnopharmacology 2025; 340 doi: 10.1016/j.jep.2024.119244
|